D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
- PMID: 33011844
- DOI: 10.1007/s00394-020-02394-y
D-allulose provides cardioprotective effect by attenuating cardiac mitochondrial dysfunction in obesity-induced insulin-resistant rats
Abstract
Purpose: Obesity-induced insulin resistant is associated with cardiovascular diseases via impairing cardiac mitochondria. Recently, D-allulose could protect β-islets and improve insulin resistance. However, the effects of D-allulose on the heart and cardiac mitochondrial function under obesity-induced insulin-resistant condition has not been investigated. In this study, we aimed to investigate the effects of D-allulose on metabolic parameters, cardiac function, heart rate variability (HRV), cardiac mitochondrial function, and apoptosis in the heart of obesity-induced insulin-resistant rats induced by chronic high fat diet consumption.
Methods: Male Wistar rats (n = 24) received a normal fat diet (ND) or high fat diet (HFD) for 12 weeks. Then, HFD group was randomly divided into three subgroups to receive (1) HFD with distilled water, (2) HFD with 3% D-allulose 1.9 g/ kg·BW/ day (HFR), and (3) HFD with metformin 300 mg/kg·BW/ day (HFM) by diluted in drinking water daily for 12 weeks. At week 24, proposed study parameters were investigated.
Results: Chronic HFD consumption induced obesity-induced insulin resistant in rats and high fat diet impaired cardiac function and HRV. HFR rats had improved insulin sensitivity as indicated by decreasing HOMA index, plasma insulin, whereas HFM decreased body weight, visceral fat, plasma cholesterol, and plasma LDL. HFR and HFM provided similar efficacy in improving HRV and attenuating cardiac mitochondrial dysfunction, leading to improved cardiac function.
Conclusions: Even though this is the first investigation of the D-allulose impact on the heart with a relatively small sample size, it clearly demonstrated a beneficial effect on the heart. D-allulose exerted a therapeutic effect on metabolic parameters except for body weight and lipid profiles and provided cardioprotective effects similar to metformin via attenuating cardiac mitochondrial function in obesity-induced insulin-resistant rats.
Keywords: Cardiovascular health; D-allulose; Diet-induced insulin resistance; Metformin; Rat model.
Similar articles
-
Not only metformin, but also D-allulose, alleviates metabolic disturbance and cognitive decline in prediabetic rats.Nutr Neurosci. 2022 Jun;25(6):1115-1127. doi: 10.1080/1028415X.2020.1840050. Epub 2020 Nov 5. Nutr Neurosci. 2022. PMID: 33151133
-
Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.J Endocrinol. 2017 Feb;232(2):189-204. doi: 10.1530/JOE-16-0406. Epub 2016 Nov 14. J Endocrinol. 2017. PMID: 27875248
-
Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.Br J Pharmacol. 2013 Jul;169(5):1048-57. doi: 10.1111/bph.12176. Br J Pharmacol. 2013. PMID: 23488656 Free PMC article.
-
Rare sugar D-allulose: Potential role and therapeutic monitoring in maintaining obesity and type 2 diabetes mellitus.Pharmacol Ther. 2015 Nov;155:49-59. doi: 10.1016/j.pharmthera.2015.08.004. Epub 2015 Aug 20. Pharmacol Ther. 2015. PMID: 26297965 Review.
-
Allulose in human diet: the knowns and the unknowns.Br J Nutr. 2022 Jul 28;128(2):172-178. doi: 10.1017/S0007114521003172. Epub 2021 Aug 19. Br J Nutr. 2022. PMID: 34409930 Review.
Cited by
-
d-Allulose Ameliorates Skeletal Muscle Insulin Resistance in High-Fat Diet-Fed Rats.Molecules. 2021 Oct 19;26(20):6310. doi: 10.3390/molecules26206310. Molecules. 2021. PMID: 34684891 Free PMC article.
-
Advances in the biosynthesis of D-allulose.World J Microbiol Biotechnol. 2024 Nov 2;40(12):375. doi: 10.1007/s11274-024-04166-w. World J Microbiol Biotechnol. 2024. PMID: 39487344 Review.
-
Polyunsaturated Fatty Acid EAB-277® Supplementation Improved Heart Rate Variability and Clinical Signs in Tracheal Collapse Dogs.Front Vet Sci. 2022 Jul 14;9:880952. doi: 10.3389/fvets.2022.880952. eCollection 2022. Front Vet Sci. 2022. PMID: 35909680 Free PMC article.
-
Short-term effects of allulose consumption on glucose homeostasis, metabolic parameters, incretin levels, and inflammatory markers in patients with type 2 diabetes: a double-blind, randomized, controlled crossover clinical trial.Eur J Nutr. 2023 Oct;62(7):2939-2948. doi: 10.1007/s00394-023-03205-w. Epub 2023 Jul 11. Eur J Nutr. 2023. PMID: 37432472 Clinical Trial.
-
Investigation of d-allulose effects on high-sucrose diet-induced insulin resistance via hyperinsulinemic-euglycemic clamps in rats.Heliyon. 2021 Sep 17;7(9):e08013. doi: 10.1016/j.heliyon.2021.e08013. eCollection 2021 Sep. Heliyon. 2021. PMID: 34589631 Free PMC article.
References
-
- DeFronzo RA, Ferrannini E, Groop L, Henry RR, Herman WH, Holst JJ, Hu FB, Kahn CR, Raz I, Shulman GI, Simonson DC, Testa MA, Weiss R (2015) Type 2 diabetes mellitus. Nat Rev Dis Primers 1:15019. https://doi.org/10.1038/nrdp.2015.19 - DOI - PubMed
-
- Gluvic Z, Zaric B, Resanovic I, Obradovic M, Mitrovic A, Radak D, Isenovic ER (2017) Link between metabolic syndrome and insulin resistance. Curr Vasc Pharmacol 15(1):30–39. https://doi.org/10.2174/1570161114666161007164510 - DOI - PubMed
-
- Engin A (2017) The definition and prevalence of obesity and metabolic syndrome. Adv Exp Med Biol 960:1–17. https://doi.org/10.1007/978-3-319-48382-5_1 - DOI - PubMed
-
- Strain WD, Paldanius PM (2018) Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol 17(1):57. https://doi.org/10.1186/s12933-018-0703-2 - DOI - PubMed - PMC
-
- Pongkan W, Pintana H, Sivasinprasasn S, Jaiwongkam T, Chattipakorn SC, Chattipakorn N (2016) Testosterone deprivation accelerates cardiac dysfunction in obese male rats. J Endocrinol 229(3):209–220. https://doi.org/10.1530/JOE-16-0002 - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical